Cite
HARVARD Citation
Oesterheld, J. et al. (2020). Phase II trial of gemcitabine and nab‐paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatric blood & cancer. 67 (7), p. n/a. [Online].